General PCR Testing Content Pathogen and ABR Detection

Modern infectious disease management demands speed, accuracy, and actionable data. Our comprehensive qPCR panels detect Gram-negative bacteria, Gram-positive bacteria, fungi, parasites, and antimicrobial resistance (ABR) genes—delivering clinically meaningful insights within hours, not days.

WHY qPCR?

COMPREHENSIVE PATHOGEN DETECTION

GRAM-NEGATIVE BACTERIA

Clinical Relevance

Gram-negative organisms are among the most common and clinically significant causes of infection, particularly in:

Key Advantages of PCR Detection
Common Targets

GRAM-POSITIVE BACTERIA

Clinical Relevance

Gram-positive pathogens are critical drivers of:

Key Advantages of qPCR Detection
Common Targets

FUNGI (YEAST & MOLDS)

Clinical Relevance

Parasitic infections contribute to:

Key Advantages of qPCR Detection
Common Targets

PARASITES

Clinical Relevance

Parasitic infections contribute to:

Key Advantages of qPCR Detection
Common Targets

ANTIMICROBIAL RESISTANCE (ABR) GENES

Turning Detection into Actionable Therapy
Why ABR Detection Matters
Traditional susceptibility testing can take 48–96 hours. PCR identifies resistance markers at the genetic level, enabling faster clinical decisions.
Clinical Impact
Common Resistance Genes Detected

Sexually Transmitted Infection (STI) — Pathogen Panel

FeatureClinical Benefit
Rapid turnaroundSame-day actionable results
High sensitivityDetects low-level infections
Broad coverageBacteria, fungi, parasites in one test
ABR gene detectionEnables targeted therapy
Culture-independentEffective post-antibiotic exposure
Polymicrobial detectionIdentifies co-infections

Clinical Applications

Earlier diagnosis

Reduced hospitalizations and complications

Improved antimicrobial stewardship

Better outcomes in complex and chronic infections

IDEAL USE CASES

Recurrent or complicated UTIs

Chronic wounds or non-healing infections

Vaginitis or STI evaluation

Respiratory infections

Immunocompromised patients

Culture-negative but clinically suspicious infections

WHY PROVIDERS CHOOSE MOLECULAR qPCR TESTING

Clinically actionable insights—not just organism identification

Faster than traditional microbiology workflows

Supports evidence-based prescribing

Aligns with modern diagnostic stewardship practices